UBS’s CLECO CRP (HOLDING CO) CNL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$2.26M Sell
47,013
-2,219
-5% -$123K ﹤0.01% 2790
2014
Q2
$2.9M Buy
49,232
+3,530
+8% +$184K ﹤0.01% 2510
2014
Q1
$2.31M Sell
45,702
-5,665
-11% -$274K ﹤0.01% 2630
2013
Q4
$2.39M Buy
51,367
+8,137
+19% +$374K ﹤0.01% 2626
2013
Q3
$1.94M Sell
43,230
-4,417
-9% -$206K ﹤0.01% 2624
2013
Q2
$2.21M Buy
+47,647
New +$2.23M ﹤0.01% 2442

Other funds holding CNL

UBS's CNL Position: Q3 2014 in Review

UBS reduced its CLECO CRP (HOLDING CO) (CNL) stake by 4.5% in Q3 2014, selling an estimated $123K and leaving 47,013 shares worth $2.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2790.

UBS first reported a position in CNL in Q2 2013 and has held it in 6 quarters since. The position peaked at $2.9M in Q2 2014. 247 funds tracked by Wall St. Rank hold CNL as of Q3 2014.

  • UBS held 47,013 shares of CLECO CRP (HOLDING CO) worth $2.26M as of Q3 2014.
  • UBS sold 2,219 CLECO CRP (HOLDING CO) shares in Q3 2014, an estimated $123K.
  • CLECO CRP (HOLDING CO) made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2790 holding.
  • UBS first reported a position in CLECO CRP (HOLDING CO) in Q2 2013 and has held it in 6 quarters since.
  • UBS's CLECO CRP (HOLDING CO) position peaked at $2.9M in Q2 2014.
  • 247 funds tracked by Wall St. Rank held CLECO CRP (HOLDING CO) as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.